Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ATNX - Athenex to acquire Kuur Therapeutics in $185M deal

ATNX - Athenex to acquire Kuur Therapeutics in $185M deal

Athenex Inc.
Clinical stage biopharmaceutical company Athenex (ATNX) has acquired immunotherapy developer Kuur Therapeutics in a deal valued at $185M, in a bid to bolster its cell therapy portfolio.The deal includes an upfront payment of $70M and potential milestone payments of up to $115M."Kuur’s innovative technology, combined with our TCR program, could propel us into a leadership position in cell therapy," Athenex CEO Johnson Lau said.Athenex shares were up marginally during after-market trading.

For further details see:

Athenex to acquire Kuur Therapeutics in $185M deal
Stock Information
Company Name: Athenex Inc.
Stock Symbol: ATNX
Market: NASDAQ
Menu
ATNX ATNX Quote ATNX Short ATNX News ATNX Articles ATNX Message Board
Get ATNX Alerts

News, Short Squeeze, Breakout and More Instantly...